Biologics News

Patients who underwent rotator cuff repair using platelet-rich plasma prepared by apheresis and applied in the liquid state with thrombin did not experience better clinical results, according to results of a prospective, double-blind study.

DePuy Synthes, in collaboration with LifeNet Health, recently announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects.

Compared with high tibial osteotomy with platelet-rich plasma injection only, patients who underwent high tibial osteotomy in conjunction with mesenchymal stem cell therapy and platelet-rich plasma injection had mildly improved cartilage healing and good clinical results, according to study results.

Stem cells have demonstrated promise across all facets of medicine, including sports medicine, where early results have exhibited the potential for enhanced cartilage, tendon and meniscal healing.

Synergy Biomedical recently announced it was issued a core patent that broadly covers the use of its Biosphere particles in a variety of bone healing products.

Stem cells have demonstrated promise across all facets of medicine, including sports medicine, where early results have exhibited the potential for enhanced cartilage, tendon and meniscal healing.

Recently published data indicated a program of rehabilitation and platelet-rich plasma therapy may be more beneficial in patients with an acute hamstring injury than rehabilitation alone.  

Bacterin International Holdings recently announced the launch of a new demineralized allograft, 3Demin Cortical Fibers.

Wright Medical Group recently announced its subsidiary, BioMimetic, received an approvable letter in its premarket approval application from the FDA for the company’s Augment Bone Graft.

Globus Medical announced recently that it has acquired Transplant Technologies of Texas.